m 6 A‑modified HOXC10 promotes HNSCC progression via co‑activation of ADAM17/EGFR and Wnt/β‑catenin signaling
International Journal of Oncology · 2023
DOI: 10.3892/ijo.2023.5598 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Oncology, 2023. Verfasst von Yujuan Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Eye and ENT Hospital, Fudan University, Shanghai 200031, P.R. China. Hauptthemen laut MEDLINE: ADAM17 Protein, Genes, Homeobox, Head and Neck Neoplasms, Homeodomain Proteins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Eye and ENT Hospital, Fudan University, Shanghai 200031, P.R. China.
- Liver Cancer Institute, Zhongshan Hospital, Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai 200032, P.R. China.
Zitieren
APA
Zhou, Y., Huang, Q., Wu, C., Xu, Y., Guo, Y., Yuan, X., Xu, C., & Zhou, L. (2023). m 6 A‑modified HOXC10 promotes HNSCC progression via co‑activation of ADAM17/EGFR and Wnt/β‑catenin signaling. International Journal of Oncology. https://doi.org/10.3892/ijo.2023.5598
Vancouver
Zhou Y, Huang Q, Wu C, Xu Y, Guo Y, Yuan X, et al. m 6 A‑modified HOXC10 promotes HNSCC progression via co‑activation of ADAM17/EGFR and Wnt/β‑catenin signaling. International Journal of Oncology. 2023. doi:10.3892/ijo.2023.5598
BibTeX
@article{Zhou2023,
author = {Zhou, Yujuan and Huang, Qiang and Wu, Chunping and Xu, Ye and Guo, Yang and Yuan, Xiaohui and Xu, Chengzhi and Zhou, Liang},
title = {m 6 A‑modified HOXC10 promotes HNSCC progression via co‑activation of ADAM17/EGFR and Wnt/β‑catenin signaling},
journal = {International Journal of Oncology},
year = {2023},
doi = {10.3892/ijo.2023.5598}
}
EUVIMED